Co-Diagnostics, Inc. Increase (Decrease) in Deferred Income Taxes
Co-Diagnostics, Inc. (CODX) reported Increase (Decrease) in Deferred Income Taxes of $142.17 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2021-08-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredIncomeTaxes · last filed 2021-08-12
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2021-06-30 was -$4.34K.
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2021-03-31 was $146.52K.
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2020-12-31 was $435.80K, a 14127.78% increase year-over-year.
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for the quarter ending 2020-09-30 was $304.44K.
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for fiscal 2020 was -$303.98K.
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for fiscal 2019 was -$1.32K, a 100.68% decline from fiscal 2018.
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for fiscal 2018 was $194.34K.
- Co-Diagnostics, Inc. increase (decrease) in deferred income taxes for fiscal 2017 was -$194.34K, a 141.08% decline from fiscal 2016.
| Period end | Increase (Decrease) in Deferred Income Taxes 3 month | Increase (Decrease) in Deferred Income Taxes 6 month | Increase (Decrease) in Deferred Income Taxes 6 month as first filed | Increase (Decrease) in Deferred Income Taxes 9 month | Increase (Decrease) in Deferred Income Taxes 9 month as first filed | Increase (Decrease) in Deferred Income Taxes 12 month | Increase (Decrease) in Deferred Income Taxes 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-06-30 | -$4.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $142.17K 10-Q · filed 2021-08-12 | $577.97K derived: sum of 3 quarters · filed 2021-08-12 | $882.41K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2021-03-31 | $146.52K 10-Q · filed 2021-05-13 | $582.31K derived: sum of 2 quarters · filed 2021-05-13 | $886.76K derived: sum of 3 quarters · filed 2021-05-13 | $285.54K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-12-31 | $435.80K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $740.24K derived: sum of 2 quarters · filed 2021-03-25 | $139.03K derived: sum of 3 quarters · filed 2021-08-12 | -$303.98K 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $304.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | -$296.77K derived: sum of 2 quarters · filed 2021-08-12 | -$739.78K 10-Q · filed 2020-11-16 | -$736.72K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-06-30 | -$601.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$1.04M 10-Q · filed 2021-08-12 | -$1.04M derived: sum of 3 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$443.01K 10-Q · filed 2021-05-13 | -$439.95K derived: sum of 2 quarters · filed 2021-05-13 | |||||
| 2019-12-31 | $3.06K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | -$1.32K 10-K · filed 2021-03-25 | |||||
| 2019-09-30 | -$4.39K 10-Q · filed 2020-11-16 | ||||||
| 2018-12-31 | $165.25K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $174.95K derived: sum of 2 quarters · filed 2020-03-30 | $184.64K derived: sum of 3 quarters · filed 2020-03-30 | $194.34K 10-K · filed 2020-03-30 | |||
| 2018-09-30 | $9.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $19.39K derived: sum of 2 quarters · filed 2019-11-12 | $29.09K 10-Q · filed 2019-11-12 | $31.69K derived: sum of 4 quarters · filed 2019-11-12 | |||
| 2018-06-30 | $9.70K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $19.39K 10-Q · filed 2019-08-14 | $21.99K derived: sum of 3 quarters · filed 2019-08-14 | $24.59K derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $9.70K 10-Q · filed 2019-05-14 | $12.29K derived: sum of 2 quarters · filed 2019-05-14 | $14.89K derived: sum of 3 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $2.60K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $5.20K derived: sum of 2 quarters · filed 2019-04-01 | -$194.34K 10-K · filed 2019-04-01 | $194.34K 10-K · filed 2018-03-28 | |||
| 2017-09-30 | $2.60K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$196.94K 10-Q · filed 2018-11-14 | $196.94K 10-Q · filed 2017-11-14 | ||||
| 2017-06-30 | -$199.53K 10-Q · filed 2018-08-10 | $199.53K 10-Q · filed 2017-08-25 | |||||
| 2016-12-31 | $473.06K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |